HighTower Advisors
ONCS

HighTower Advisors’s OncoSec Medical Incorporated ONCS Stock Holding History

HighTower Advisors’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-941
Closed -$45K – 3598
2021
Q3 		$45K Buy
+941
New +$47.7K ﹤0.01% 2947

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

HighTower Advisors's ONCS Position: Q4 2021 in Review

HighTower Advisors sold out of OncoSec Medical Incorporated (ONCS) in Q4 2021, closing a stake of 941 shares — an estimated $45K sold.

HighTower Advisors first reported a position in ONCS in Q3 2021 and held it in 1 quarter. The position peaked at $45K in Q3 2021. 34 funds tracked by Wall St. Rank hold ONCS as of Q4 2021.

  • HighTower Advisors reported no remaining OncoSec Medical Incorporated position as of Q4 2021 after selling out during the quarter.
  • HighTower Advisors sold 941 OncoSec Medical Incorporated shares in Q4 2021, an estimated $45K.
  • HighTower Advisors first reported a position in OncoSec Medical Incorporated in Q3 2021 and held it in 1 quarter.
  • HighTower Advisors's OncoSec Medical Incorporated position peaked at $45K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2021.

Based on HighTower Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.